Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00686933 · COMPLETED

Trial details

NCT number: NCT00686933
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2008-05-01
Primary completion: 2008-10-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.